In the time of COVID‐19, predictive molecular pathology laboratories must still timely select oncological patients for targeted treatments. However, the need to respect social distancing measures may delay results generated by laboratory-developed tests based on sequential steps a long hands‐on time.
Laboratory workflows should now be simplified*.
*Malapelle U, et al. J Clin Pathol 2020;0:1–5. doi:10.1136/jclinpath-2020-206957